Terumo: FDA 510(k) clearances across all its applicant names
FDA lists 563 510(k) clearances, 12 PMA and 0 De Novo decisions across the 25 applicant names Caduvo groups under Terumo, first 1976, latest 2026. Median 510(k) review time across these names: 73 days. Since 2017 the median was 174 days, against 138 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 20 | 53 |
| 2013 | 17 | 57 |
| 2014 | 15 | 158 |
| 2015 | 26 | 84 |
| 2016 | 9 | 84 |
| 2017 | 13 | 175 |
| 2018 | 11 | 174 |
| 2019 | 8 | 115 |
| 2020 | 7 | 90 |
| 2021 | 5 | 202 |
| 2022 | 5 | 264 |
| 2023 | 7 | 197 |
| 2024 | 5 | 210 |
| 2025 | 10 | 140 |
| 2026 | 5 | 192 |
The 25 FDA applicant names in this group
| Applicant name | 510(k) clearances | PMA | De Novo | Years |
|---|---|---|---|---|
| Terumo Medical Corp. | 157 | 3 | 0 | 1980–2023 |
| MicroVention, Inc. | 86 | 4 | 0 | 2001–2025 |
| 3M Health Care, Sarns | 76 | 0 | 0 | 1976–1996 |
| Terumo Cardiovascular Systems Corp. | 74 | 0 | 0 | 2000–2024 |
| Terumo Corp. | 34 | 0 | 0 | 1991–2026 |
| Terumo America, Inc. | 31 | 0 | 0 | 1976–1981 |
| Terumo Europe N.V. | 28 | 0 | 0 | 1999–2025 |
| Vascutek, Ltd. | 26 | 1 | 0 | 1991–2025 |
| Terumobct, Inc. | 8 | 0 | 0 | 2013–2019 |
| Ashitaka Factory of Terumo Corporation | 6 | 0 | 0 | 2013–2021 |
| Harvest Technologies, Corp. | 6 | 0 | 0 | 2001–2012 |
| Terumo Medical Products (Hangzhou) Co., Ltd. | 5 | 0 | 0 | 2003–2025 |
| Terumo (Philippines) Corporation | 5 | 0 | 0 | 2012–2015 |
| Kofu Factory of Terumo Corp. | 4 | 0 | 0 | 2005–2014 |
| Harvest Technologies, LLC | 3 | 0 | 0 | 1999–2000 |
| MicroVention, Inc., d/b/a Terumo Neuro | 3 | 0 | 0 | 2026–2026 |
| Caridianbct, Inc.. | 2 | 0 | 0 | 2010–2012 |
| Terumo Clinical Supply Co., Ltd. | 2 | 0 | 0 | 2021–2026 |
| Bolton Medical, Inc. | 1 | 3 | 0 | 2002–2002 |
| Gambro Bct, Inc. | 1 | 1 | 0 | 2007–2007 |
| Ashitaka Factory of Terumo Coporation | 1 | 0 | 0 | 2017–2017 |
| MicroVention, Inc. A TERUMO Group Company | 1 | 0 | 0 | 2019–2019 |
| Terumo Bct | 1 | 0 | 0 | 2015–2015 |
| Terumo Cardiovascular Systems Thi Plant | 1 | 0 | 0 | 2025–2025 |
| Terumo Medical Coporation | 1 | 0 | 0 | 2019–2019 |
Review time against the same product codes
Since 2017, 510(k)s cleared under these names took a median 174 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 138 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DTZ | Oxygenator, Cardiopulmonary Bypass | 39 | 39 |
| DWF | Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass | 33 | 33 |
| HCG | Device, Neurovascular Embolization | 32 | 32 |
| FMI | Needle, Hypodermic, Single Lumen | 30 | 30 |
| DYB | Introducer, Catheter | 29 | 29 |
| DQY | Catheter, Percutaneous | 24 | 24 |
| DSY | Prosthesis, Vascular Graft, Of 6mm And Greater Diameter | 22 | 22 |
| DQX | Wire, Guide, Catheter | 20 | 20 |
| FMF | Syringe, Piston | 20 | 20 |
| FPA | Set, Administration, Intravascular | 18 | 18 |
Plus 118 more product codes.
Review panels
- Cardiovascular (326)
- General Hospital (97)
- Gastroenterology and Urology (49)
- Neurology (48)
- Clinical Chemistry (21)
- General and Plastic Surgery (15)
- Anesthesiology (5)
- Dental (3)
- Hematology (2)
- Obstetrics and Gynecology (2)
- Immunology (1)
- Ophthalmic (1)
- Orthopedic (1)
- Clinical Toxicology (1)
Most recent Terumo 510(k) clearances
| 510(k) | Device | Applicant name | Product code | Decision date | Review days |
|---|---|---|---|---|---|
| K261376 | Progreat Lambda 2.1Fr | Terumo Clinical Supply Co., Ltd. | KRA | 2026-11-05 | 192 |
| K254035 | Mayumi Thrombectomy System | MicroVention, Inc., d/b/a Terumo Neuro | QEZ | 2026-09-03 | 261 |
| K261808 | ISAAC Neurovascular Navigation Catheter | MicroVention, Inc., d/b/a Terumo Neuro | QJP | 2026-06-30 | 29 |
| K261549 | BOBBY Balloon Guide Catheter | MicroVention, Inc., d/b/a Terumo Neuro | QJP | 2026-06-09 | 29 |
| K252295 | Ryurei | Terumo Corp. | LOX | 2026-03-27 | 247 |
| K252402 | Midline Catheter | Terumo Medical Products (Hangzhou) Co., Ltd. | PND | 2025-12-18 | 140 |
| K252398 | SURFLO Hybria Closed System Safety IV Catheter | Terumo Medical Products (Hangzhou) Co., Ltd. | FOZ | 2025-12-17 | 139 |
| K250700 | Pen Injector Needle 32.5 | Terumo Corp. | FMI | 2025-11-21 | 259 |
| K250751 | DualView Catheter | Terumo Corp. | DQO | 2025-07-17 | 127 |
| K251447 | K-Pack Embrace Active Safety Needle (KNAS-2516RB, KNAS-2525RB) | Terumo Europe N.V. | FMI | 2025-07-08 | 60 |
553 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P210030 | PMA | Roadsaver/CASPER Carotid Stent Device | 2024-11-20 |
| P210017 | PMA | Cross-Seal Suture-Mediated Vascular Closure Device System | 2023-09-26 |
| P210006 | PMA | Thoraflex Hybrid | 2022-04-19 |
| P200045 | PMA | RelayPro Thoracic Stent-Graft System | 2021-08-05 |
| P190015 | PMA | TREO® Abdominal Stent-Graft System | 2020-05-04 |
Recalls
673 product recalls in 220 recall events under these names; 25 initiated in the last five years.
9 product recalls in 8 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 0 initiated in the last five years. Most often: Asahi Medical Co Ltd (2), Caridian BCT, Incorporated (2), St. Jude Medical / Daig Division (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
ClinicalTrials.gov lists 75 device studies (15 active or recruiting) with an industry lead sponsor under the 6 sponsor names below. Most recent:
- NCT07911163: Clinical Health Outcomes Evaluation of Terumo Aortic Hybrid Devices (Vascutek Ltd.; Not yet recruiting, started 2027-05)
- NCT07888738: Evaluation of Safety, Performance and Usability of the TR Band DISTAL Device for Hemostasis Following Distal Radial Access in Coronary Procedures (Terumo Europe N.V.; Not yet recruiting, started 2026-12-01)
- NCT07078383: A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta (Vascutek Ltd.; Recruiting, started 2025-12-19)
- NCT07026877: Endovascular Repair With Fenestrated TREO Stent-Graft System in AAA (Bolton Medical; Suspended, started 2025-11-18)
- NCT06893952: Technical Evaluation and Results of the Use of TREO® Modular Aortic Endografts for the Treatment of Abdominal Aortic Aneurysms (Vascutek Ltd.; Not yet recruiting, started 2025-04)
| Lead sponsor name on ClinicalTrials.gov | Device studies |
|---|---|
| Terumo Europe N.V. | 22 |
| Terumo BCT | 14 |
| Bolton Medical | 13 |
| Vascutek Ltd. | 13 |
| Terumo Medical Corporation | 7 |
| Harvest Technologies | 6 |
Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.
How this group is built
Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
3M's Sarns cardiovascular business (1999, now Terumo Cardiovascular), MicroVention (2006), CaridianBCT (formerly Gambro BCT, 2011, now Terumo Blood and Cell Technologies), Vascutek and Bolton Medical (2017). Includes filings made before each acquisition. Left out: COBE Laboratories (its businesses split among Terumo, Gambro and Sorin), joint ventures.
Sources
Frequently asked questions
How many FDA 510(k) clearances are listed across Terumo's applicant names?
FDA lists 563 510(k) clearances, 12 PMA and 0 De Novo decisions across the 25 applicant names Caduvo groups under Terumo, first 1976, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.
Which FDA applicant names does Terumo file under?
The names with the most 510(k) clearances in this group are Terumo Medical Corp. (157); MicroVention, Inc. (86); 3M Health Care, Sarns (76); Terumo Cardiovascular Systems Corp. (74); Terumo Corp. (34). The full list of 25 names is on this page.
How long does FDA take to clear Terumo 510(k)s?
The median time from FDA receipt to decision across 510(k)s cleared under these names is 73 days. Since 2017 the median was 174 days, against 138 days for all cleared 510(k)s in the same product codes.
Does the Terumo count include acquired companies?
Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.
How many device clinical trials does Terumo sponsor?
ClinicalTrials.gov lists 75 device studies (15 active or recruiting) with an industry lead sponsor under 6 sponsor names Caduvo groups under Terumo. ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.
Next steps
- See all 563 Terumo clearances with predicates and recalls
- Run predicate analysis for product code DTZ, Terumo's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.
All parent companies · FDA device companies by applicant name · FDA product code lookup